Latest filing published 19 Jun 2025 for HLS Therapeutics Inc..
This profile gathers the share dealings of Dawn Edinboro in HLS Therapeutics Inc. We count 3 filings; the first trade dates from 17 June 2022 and the latest from 18 June 2025.
Purchases make up the whole of the open-market record (2 purchases, €2,212). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 2 purchases and no sales.
Most recently, on 19 June 2025, the filings show a transaction in HLS Therapeutics Inc. The last purchase on record was published on 19 June 2025, which is 494 days ago. Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations